Dupilumab as Effective Therapy for Corticosteroid- Dependent/Resistant Type 2 Inflammation-Related Cutaneous Adverse Reactions

J Investig Allergol Clin Immunol. 2024 Apr;34(2):145-147. doi: 10.18176/jiaci.0944.NO ABSTRACTPMID:38639452 | DOI:10.18176/jiaci.0944

Source: Journal of Investigational Allergology and Clinical Immunology - April 19, 2024 Category: Allergy & Immunology Authors: C Shen N Wu L Yang B Wang T Liu J Tao Source Type: research